Galena Biopharma, Inc.
Galena Biopharma, Inc. (GALE) is a publicly traded company in the Unknown sector. Across all available filings, 15 corporate insiders have executed 116 transactions totaling $16.5M, demonstrating a bearish sentiment with -$16.3M in net insider flow. The most recent transaction on Oct 10, 2017 involved a transaction of 12,708 shares valued at $4.8K.
GALE Insider Activity Summary
Who Is Buying GALE Stock?
No significant insider buying has been recorded for GALE in the recent period.
Who Is Selling GALE Stock?
No significant insider selling has been recorded for GALE in the recent period.
Is Galena Biopharma, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for GALE is bearish with an Insider Alignment Score of 1/100 and a net flow of -$16.3M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
GALE Frequently Asked Questions
Understanding GALE Insider Activity
Insider trading at Galena Biopharma, Inc. (GALE) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 15 insiders are actively trading GALE stock, having executed 116 transactions in the past 90 days. The most active insider is Mark J. Ahn (Executive), who has made 14 transactions totaling $5.0M.
Related Tools
Track Galena Biopharma, Inc. Insider Activity
Get notified when executives and directors at GALE file new Form 4 transactions